Page 50 - DIAGEN
P. 50

Solid Tumor  primeFISH Products


              SOLIDTUMOR

              PANEL



              17-220 NTRK3 (15q25) BREAKAPART



              NTRK3 is a receptor tyrosine kinase (TK) for neurotro-  thyroid cancer, secretory breast carcinoma, and mammary
              phin 3 (NT3) and plays an important role in celi survival   analogue secretory carcinoma of the salivary gland. The
              and development of the central and peripheral nervous   most common rearrangement involving the NTRK3 gene
              systems. Transloca  tions affecting the NTRK3 gene have   is t(12;15) (pl3;q25); Asa result, fusion occurs between the
              been reported in many cancer types, including glioblas    5’ part of the ETV6 gene and the 3’ part of the NTRK3 gene.
              tomas, Philadelphia chromosome-like acute lymphoblastic   This fusion gene encodes a hybrid protein consisting of
              leukemia, congenital fibrosarco  mas, cellular mesoblastic   the TK portion of NTRK3 and the dimerization portion of
              nephromas, acute myeloid leukemia, radiation-associated   ETV6, resulting in a ligand-independent TK activity.


















                                                                              BREAKAPART






                            D15S1119  D15S99      SHGC-102137  D15S168E
                                             3'  5'
                                                                                NORMAL
                         Gen                                     Tel
                                           NTRK3

                                494 kb                  813 kb



                                                                               DELETION
                     15q25.3-q26.1



                               (Not to scale)








      www.diagen.com.tr  References
              Amatu A, et al. (2016) ESMO Open 1: e000023.
              Nagasubramanian R, et al. (2016) Pediatr Blood Cancer 63: 1468-70.
              Wang L, et al. (2017) J Mol Diagn 19: 387-96.





       50     PRODUCT CATALOGUE     info@diagen.com.tr
   45   46   47   48   49   50   51   52   53   54   55